XFOR
X4 Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
2.23 / 10
Underperform
Technical analysis rates the stock 2.23/10, classifying it as underperforming. All three examined candlestick patterns—Marubozu White, Long Upper Shadow and Dark Cloud Cover—show neutral to bearish bias, with bearish signals outnumbering bullish ones, suggesting heightened downside risk.
Analysis Checks(0/3)
Long Upper Shadow
Score3.62/10
Win Rate47.44%
Hist. Signals78
Avg Return2.50%
Score3.62/10
Win Rate47.44%
Hist. Signals78
Avg Return2.50%
Marubozu White
Score2.06/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.86%
Score2.06/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.86%
Dark Cloud Cover
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-1.08%
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-1.08%
Long Upper Shadow
Score3.62/10
Win Rate47.44%
Hist. Signals78
Avg Return2.50%
Score3.62/10
Win Rate47.44%
Hist. Signals78
Avg Return2.50%
Dark Cloud Cover
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-1.08%
Score1/10
Win Rate33.33%
Hist. Signals3
Avg Return-1.08%
Marubozu White
Score2.06/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.86%
Score2.06/10
Win Rate46.15%
Hist. Signals13
Avg Return-1.86%
What is the current technical signals for XFOR?
- XFOR presents a Underperform setup with a Technical Score of 2.23/10. Key technical indicators highlight an RSI of 57.64 and a MACD of 0.02, with the trend anchored by the 50-Day SMA at 3.73. Traders should monitor key support at 3.99 and resistance at 4.26.
